Quantitative Alterations in Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Background: Reduced short-chain fatty acids (SCFAs) in inflammatory bowel disease (IBD) impair the gut barrier and immune function, promoting inflammation and highlighting microbiome-targeted therapies’ therapeutic potential. The purpose of this meta-analysis was to study the changes in SCFAs in IBD...
Saved in:
| Main Authors: | Laura Chulenbayeva, Zharkyn Jarmukhanov, Karlygash Kaliyekova, Samat Kozhakhmetov, Almagul Kushugulova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/7/1017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between calprotectin and volatile fatty acids in patients with inflammatory bowel diseases
by: Yu. M. Stepanov, et al.
Published: (2023-04-01) -
Ability of short-chain fatty acids to reduce inflammation and attract leucocytes to the inflamed skin of gilthead seabream (Sparus aurata L.)
by: Nora Albaladejo-Riad, et al.
Published: (2024-12-01) -
Short-chain fatty acids (SCFAs) in gut health: Implications for drug metabolism and therapeutics
by: P. Sankarganesh, et al.
Published: (2025-09-01) -
Rapid gas chromatogram determination of methane, organic acid in in vitro ruminal fermentation products
by: HU Wei-lian, et al.
Published: (2006-03-01) -
B cell-helping functions of gut microbial metabolites
by: Chang H. Kim
Published: (2016-09-01)